Publication:
Malignancy risk in systemic lupus erythematosus patients treated with cyclophosphamide

Simple item page
dc.contributor.authorYilmaz, N.
dc.contributor.authorEmmungil, H.
dc.contributor.authorGücenmez, S.
dc.contributor.authorÖzen, G.
dc.contributor.authorYıldız, F.
dc.contributor.authorBalkarlı, A.
dc.contributor.authorKimyon, G.
dc.contributor.authorCoşkun, B. Necdet
dc.contributor.authorDoğan, I.
dc.contributor.authorPamuk, O. N.
dc.contributor.authorYaşar, S.
dc.contributor.authorCetin, G. Yildirim
dc.contributor.authorYazıcı, A.
dc.contributor.authorEsmen, S. Ergülü
dc.contributor.authorCağatay, Y.
dc.contributor.authorYılmaz, S.
dc.contributor.authorCelle, A.
dc.contributor.authorCefle, A.
dc.contributor.authorSayarhoğlu, M.
dc.contributor.authorKaşifoğlu, T.
dc.contributor.authorKaradağ, O.
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorDalkılıç, Ediz
dc.contributor.authorKısacık, B.
dc.contributor.authorCobankara, V.
dc.contributor.authorErken, E.
dc.contributor.authorDireskeneli, H.
dc.contributor.authorAksu, K.
dc.contributor.authorYavuz, S.
dc.contributor.buuauthorCOŞKUN, NEJDET
dc.contributor.buuauthorPEHLİVAN, YAVUZ
dc.contributor.buuauthorDALKILIÇ, HÜSEYİN EDİZ
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bölümü
dc.contributor.orcid0000-0003-0298-4157
dc.contributor.researcheridETE-5180-2022
dc.contributor.researcheridAAG-8227-2021
dc.contributor.researcheridAAG-7155-2021
dc.date.accessioned2024-08-12T06:16:53Z
dc.date.available2024-08-12T06:16:53Z
dc.date.issued2015-05-01
dc.descriptionBu çalışma, 02-06, Eylül 2015 tarihlerinde Vienna[Avusturya]’da düzenlenen 11. International Congress on Systemic Lupus Erythematosus Kongresi‘nde bildiri olarak sunulmuştur.
dc.identifier.endpageS67
dc.identifier.issn0392-856X
dc.identifier.issue3
dc.identifier.startpageS67
dc.identifier.urihttps://hdl.handle.net/11452/43882
dc.identifier.volume33
dc.identifier.wos000360421900240
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherClinical & Exper Rheumatology
dc.relation.journalClinical and Experimental Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRheumatology
dc.subjectRheumatology
dc.titleMalignancy risk in systemic lupus erythematosus patients treated with cyclophosphamide
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublication0041a709-5005-4d5d-951f-94e7d0932f3b
relation.isAuthorOfPublication0075f2ae-ae8a-4690-bd46-128775e8efac
relation.isAuthorOfPublication1613225c-2f43-4052-9f82-210c854edcf4
relation.isAuthorOfPublication.latestForDiscovery0041a709-5005-4d5d-951f-94e7d0932f3b

Files

Collections

Yeni Yayınlar